human | Q5 |
P2671 | Google Knowledge Graph ID | /g/11fym29yz6 |
P496 | ORCID iD | 0000-0002-5477-8585 |
P1153 | Scopus author ID | 7004418512 |
P166 | award received | Officer of the Order of the British Empire | Q10762848 |
Andre Mayer award | Q125256785 | ||
P69 | educated at | University of London | Q170027 |
Imperial College London | Q189022 | ||
P108 | employer | University College London | Q193196 |
University College Hospital | Q3551343 | ||
P734 | family name | Batterham | Q65683837 |
Batterham | Q65683837 | ||
Batterham | Q65683837 | ||
P735 | given name | Rachel | Q935489 |
Rachel | Q935489 | ||
P106 | occupation | physiologist | Q2055046 |
P21 | sex or gender | female | Q6581072 |
Q36360575 | A case of severe anorexia, excessive weight loss and high peptide YY levels after sleeve gastrectomy |
Q34358429 | A link between FTO, ghrelin, and impaired brain food-cue responsivity |
Q47173582 | A pilot study of primary care physicians' attitude to weight loss surgery in England: are the young more prejudiced? |
Q90024721 | A randomized crossover trial assessing the effects of acute exercise on appetite, circulating ghrelin concentrations, and butyrylcholinesterase activity in normal-weight males with variants of the obesity-linked FTO rs9939609 polymorphism |
Q92777704 | A switch from high-fat to normal diet does not restore sperm quality but prevents metabolic syndrome |
Q30479831 | AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons |
Q57499718 | Acute and Chronic Effects of Exercise on Appetite, Energy Intake and Appetite-Related Hormones: the Modulating Effect of Adiposity, Sex and Habitual Physical Activity |
Q57168069 | Acute and Chronic Effects of Exercise on Appetite, Energy Intake, and Appetite-Related Hormones: The Modulating Effect of Adiposity, Sex, and Habitual Physical Activity |
Q92593883 | Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial |
Q35718378 | Age- and sex-specific effects on weight loss outcomes in a comparison of sleeve gastrectomy and Roux-en-Y gastric bypass: a retrospective cohort study. |
Q42699253 | Appetite and Energy Intake Responses to Acute Energy Deficits in Females versus Males |
Q52839510 | Appetite and gut peptide responses to exercise and calorie restriction. The effect of modest energy deficits. |
Q45198021 | Appetite, energy intake, and PYY3-36 responses to energy-matched continuous exercise and submaximal high-intensity exercise |
Q51510731 | Attenuated peptide YY release in obese subjects is associated with reduced satiety. |
Q35875543 | Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care |
Q94585668 | Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery |
Q104106202 | Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses |
Q47181618 | Body Contouring Surgery and the Maintenance of Weight-Loss Following Roux-En-Y Gastric Bypass: A Retrospective Study |
Q98191994 | British Obesity and Metabolic Surgery Society Guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery-2020 update |
Q46310909 | Can glucose make you faint? |
Q93201861 | Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP |
Q31126427 | Contribution of 32 GWAS-identified common variants to severe obesity in European adults referred for bariatric surgery |
Q28261574 | Critical role for peptide YY in protein-mediated satiation and body-weight regulation |
Q34615377 | Deletion of Lkb1 in pro-opiomelanocortin neurons impairs peripheral glucose homeostasis in mice |
Q37036114 | Deletion of the von Hippel-Lindau gene in pancreatic beta cells impairs glucose homeostasis in mice. |
Q34615425 | Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY. |
Q100522982 | Diet during early life defines testicular lipid content and sperm quality in adulthood |
Q51380901 | Differential acylated ghrelin, peptide YY3-36, appetite, and food intake responses to equivalent energy deficits created by exercise and food restriction. |
Q37471710 | Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans |
Q34635160 | Differential pre-mRNA splicing regulates Nnat isoforms in the hypothalamus after gastric bypass surgery in mice |
Q42937219 | Dominant role of the p110beta isoform of PI3K over p110alpha in energy homeostasis regulation by POMC and AgRP neurons |
Q46500786 | Early Effect of Bariatric Surgery on Urogenital Function in Morbidly Obese Men. |
Q35578115 | Early postoperative weight loss predicts maximal weight loss after sleeve gastrectomy and Roux-en-Y gastric bypass |
Q94467493 | Endocrinology of the Gut and the Regulation of Body Weight and Metabolism |
Q86178068 | Enteroendocrine MC4R and energy balance: linking the long and the short of it |
Q38779718 | Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity |
Q89837617 | Erratum. Evaluation of the Genetic Association Between Adult Obesity and Neuropsychiatric Disease. Diabetes 2019;68:2235-2246 |
Q55081230 | Evaluation of a 12-week lifestyle education intervention with or without partial meal replacement in Thai adults with obesity and metabolic syndrome: a randomised trial. |
Q90044101 | Evaluation of the Genetic Association Between Adult Obesity and Neuropsychiatric Disease |
Q28252794 | Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice |
Q35823876 | Feasibility and Impact of a Combined Supervised Exercise and Nutritional-Behavioral Intervention following Bariatric Surgery: A Pilot Study |
Q38307449 | GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery? |
Q33517084 | Gaining new insights into food reward with functional neuroimaging |
Q59350127 | Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK |
Q34143493 | Gut hormone PYY(3-36) physiologically inhibits food intake |
Q47356520 | Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters |
Q30378465 | Gut hormones: implications for the treatment of obesity. |
Q38782423 | Individual Variation in Hunger, Energy Intake, and Ghrelin Responses to Acute Exercise |
Q46262211 | Influence of resistance and aerobic exercise on hunger, circulating levels of acylated ghrelin, and peptide YY in healthy males |
Q57099309 | Influence of rest and exercise at a simulated altitude of 4,000 m on appetite, energy intake, and plasma concentrations of acylated ghrelin and peptide YY |
Q28204942 | Inhibition of food intake in obese subjects by peptide YY3-36 |
Q57130632 | Is Pre-operation Social Connectedness Associated with Weight Loss up to 2 Years Post Bariatric Surgery? |
Q90010843 | Joint international consensus statement for ending stigma of obesity |
Q43087653 | Latent autoimmune diabetes in adults presenting as diabetes "recurrence" after bariatric surgery: a case report |
Q55359645 | Long-term effects of bariatric surgery on acute kidney injury: a propensity-matched cohort in the UK Clinical Practice Research Datalink. |
Q37687612 | Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery. |
Q53784109 | Mechanisms of Diabetes Improvement Following Bariatric/Metabolic Surgery. |
Q57146179 | Metabolic phenotype of skeletal muscle in early critical illness |
Q33618875 | Metabolic state alters economic decision making under risk in humans |
Q46627636 | Metformin increases fasting plasma peptide tyrosine tyrosine (PYY) in women with polycystic ovarian syndrome (PCOS). |
Q64267084 | Neural Responsivity to Food Cues in Patients With Unmedicated First-Episode Psychosis |
Q104516651 | No Influence of the Fat Mass and Obesity-Associated Gene rs9939609 Single Nucleotide Polymorphism on Blood Lipids in Young Males |
Q125256182 | Nutrients or processing? An analysis of food and drink items from the UK National Diet and Nutrition Survey based on nutrient content, the NOVA classification, and front of package traffic light labelling |
Q88564962 | Obesity Management Task Force of the European Association for the Study of Obesity Released "Practical Recommendations for the Post-Bariatric Surgery Medical Management" |
Q47842186 | Obesity, body weight regulation and the brain: Insights from fMRI. |
Q64982576 | Obesity: when is specialist referral needed? |
Q116032844 | Once-Weekly Semaglutide in Adults with Overweight or Obesity |
Q79161514 | Oxyntomodulin suppresses appetite and reduces food intake in humans |
Q91890342 | PYY is a negative regulator of bone mass and strength |
Q57978507 | PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans |
Q37054075 | Peptide YY. |
Q30375395 | Peptide YY: food for thought. |
Q37173342 | Peripheral activation of the Y2-receptor promotes secretion of GLP-1 and improves glucose tolerance |
Q47426818 | Peripheral oxyntomodulin reduces food intake and body weight gain in rats. |
Q38926146 | Potential Mechanisms Mediating Sustained Weight Loss Following Roux-en-Y Gastric Bypass and Sleeve Gastrectomy |
Q43075553 | Potential mechanisms underlying the effect of bariatric surgery on eating behaviour |
Q47656954 | Practical Recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management |
Q53432369 | Protocol for a 1-year prospective, longitudinal cohort study of patients undergoing Roux-en-Y gastric bypass and sleeve gastrectomy: the BARI-LIFESTYLE observational study. |
Q39564535 | Reported appetite, taste and smell changes following Roux-en-Y gastric bypass and sleeve gastrectomy: Effect of gender, type 2 diabetes and relationship to post-operative weight loss |
Q36538457 | Role of body composition and metabolic profile in Barrett's oesophagus and progression to cancer |
Q37862878 | Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. |
Q27000617 | Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms |
Q100406770 | Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study |
Q84074105 | Shedding pounds after going under the knife: metabolic insights from cutting the gut |
Q58088769 | Social support and trajectories of body mass index and waist to hip ratio from mid-adulthood to old age |
Q46114367 | Subject standardization, acclimatization, and sample processing affect gut hormone levels and appetite in humans |
Q39133976 | The Importance of the Gastrointestinal Tract in Controlling Food Intake and Regulating Energy Balance |
Q125117677 | The Role of Diet Quality in Mediating the Association between Ultra-Processed Food Intake, Obesity and Health-Related Outcomes: A Review of Prospective Cohort Studies |
Q35684845 | The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort |
Q38159813 | The role of gut hormone peptide YY in energy and glucose homeostasis: twelve years on. |
Q37535112 | The role of gut hormones in the regulation of body weight and energy homeostasis |
Q30475796 | The role of insulin receptor substrate 2 in hypothalamic and beta cell function. |
Q48810891 | The role of peptide YY in appetite regulation and obesity. |
Q85446617 | Timing of pregnancy in obese women after bariatric surgery |
Q46364544 | Type 2 diabetes remission 2 years post Roux-en-Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores. |
Q91615019 | Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK |
Q46554159 | Weight Loss Decreases Excess Pancreatic Triacylglycerol Specifically in Type 2 Diabetes |
Q125256176 | Who consumes ultra-processed food? A systematic review of sociodemographic determinants of ultra-processed food consumption from nationally representative samples |
Rachel Batterham | wikipedia |
Search more.